Published in J Audiov Media Med on July 01, 1985
Education Intervention on Chronotherapy for Final-Year Pharmacy Students. Pharmacy (Basel) (2015) 0.75
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Increased risk of sepsis after splenectomy. BMJ (1993) 4.26
The outcome of Crohn's disease. Br J Surg (1965) 3.83
Five to eight-year results of Leeds-York controlled trial of elective surgery for duodenal ulcer. Br Med J (1968) 3.40
The relation of sensation in the anal canal to the functional anal sphincter: a possible factor in anal continence. Gut (1963) 3.33
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Screening of urines with dipstrips: does it reduce workload and consumable costs? J Clin Pathol (1990) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Mapping disease and mortality rates using empirical Bayes estimators. J R Stat Soc Ser C Appl Stat (1991) 2.57
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med (1989) 2.43
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
Staphylococcal scalded skin syndrome. Arch Dis Child (1998) 2.40
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
Problems in the identification of potential organ donors. Misconceptions and fallacies associated with donor cards. JAMA (1984) 2.25
Health care technology and the inevitability of resource allocation and rationing decisions. Part II. JAMA (1983) 2.23
Molecular structure of serum transferrin at 3.3-A resolution. Biochemistry (1988) 2.12
Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang (2011) 2.08
Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev (1999) 2.06
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Large bowel myoelectrical activity in man. Gut (1975) 1.98
Bran tablets and diverticular disease. Br Med J (1976) 1.96
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Theatre over-shoes do not reduce operating theatre floor bacterial counts. J Hosp Infect (1991) 1.92
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation. Br J Pharmacol (1975) 1.91
Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med (1988) 1.91
Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Studies of the binding of different iron donors to human serum transferrin and isolation of iron-binding fragments from the N- and C-terminal regions of the protein. Biochem J (1978) 1.82
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res (1974) 1.77
Maternal diet and infantile colic in breast-fed infants. Lancet (1981) 1.76
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med (1982) 1.70
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
An assessment of postoperative testing for completeness of vagotomy. Br J Surg (1967) 1.69
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Revagotomy for recurrent ulcer after vagotomy and drainage for duodenal ulcer. Br J Surg (1969) 1.63
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect (1997) 1.60
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
Electrical activity of the gastric antrum in man. Br J Surg (1970) 1.58
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med (2010) 1.56
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
IADR Global Oral Health Inequalities Research Agenda (IADR-GOHIRA(R)): a call to action. J Dent Res (2013) 1.53
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51
Implications for health care policy. A social and demographic profile of hemodialysis patients in the United States. JAMA (1981) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50
Myopathy in acromegaly. Lancet (1970) 1.50
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Treatment of palatal myoclonus with sumatriptan. Mov Disord (1996) 1.48
Spontaneous and diffuse coronary artery spasm unresponsive to conventional intracoronary pharmacological therapy: a case report. Catheter Cardiovasc Interv (2000) 1.48
Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48
Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci (1982) 1.48
The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47
The effect of stimulation on the myoelectrical activity of the rectosigmoid in man. Gut (1974) 1.46
Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure. Clin Exp Pharmacol Physiol (1975) 1.45
Iron deficiency in 1- to 3-year-old children. A pediatric failure? Arch Pediatr Adolesc Med (1997) 1.45
Hypothesis testing in the polychotomous logistic model with an application to detecting gastrointestinal cancer. Stat Med (1985) 1.44
Health care technology and the inevitability of resource allocation and rationing decisions. Part I. JAMA (1983) 1.44
Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut (1979) 1.43
Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings]. Br J Pharmacol (1979) 1.42
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
Hypothyroidism. Br Med J (1972) 1.41
Protein fluorescence of nicotinamide nucleotide-dependent dehydrogenases. Biochem J (1972) 1.40